Pharma Roadshow 2024, India

Crystallography plays a key role in drug discovery and development.

Structure-based drug design requires the rapid turnaround of protein-ligand structures to medicinal chemists to drive forward lead development and generate reliable APIs economically.

Characterization of drug substances and drug products is a critical need in the pharmaceutical industry.  Single-crystal X-ray diffraction provides uniquely detailed and unambiguous information on both the API and solid forms, whether they ae co-crystals, solvates or salts.  Having a full understanding of these drug early development can help to guide further development and avoid expensive recalls later in the development process.

Although traditionally in the hands of specialists, recent advances have enabled the deployment of the technique to the walk-up lab. Instruments are today run by the APEX5 software suite which guides non-specialists towards a robust crystal structure.

These workshops will be held in Hyderabad, Bengaluru and Gandhinagar during September and will feature lectures from experts from Bruker AXS, academia, and the pharmaceutical industry.

• Crystallography in Structure-based drug design
• Unambiguous determination of API absolute structure
• Powder and single crystal XRD working together to drive solid form development.
• Advanced solid form analysis – guided solid form design
• Innovative SC-XRD Solutions for the Pharmaceutical Industry

We will also provide the opportunity to see for yourself how simple it can be to apply SC-XRD to small molecule structure determination with a hands-on class.

Who should attend?

Scientists working in all fields of drug discovery and development in academic or industrial laboratories.  If you routinely use NMR, powder diffraction and have always wondered what crystallography would add to your analyses, then this is the place for you!